NorthCrest Asset Manangement’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Buy
6,660
+649
+11% +$23.4K 0.01% 797
2026
Q1
$209K Sell
6,011
-7
-0.1% -$285 0.01% 722
2025
Q4
$252K Sell
6,018
-612
-9% -$26.6K 0.01% 727
2025
Q3
$304K Buy
6,630
+2,118
+47% +$110K 0.01% 617
2025
Q2
$245K Sell
4,512
-2,496
-36% -$137K 0.01% 572
2025
Q1
$423K Buy
7,008
+1
+0% +$64 0.01% 454
2024
Q4
$480K Sell
7,007
-242
-3% -$16.9K 0.01% 406
2024
Q3
$521K Buy
7,249
+65
+0.9% +$4.59K 0.02% 392
2024
Q2
$498K Buy
7,184
+4
+0.1% +$292 0.02% 385
2024
Q1
$575K Sell
7,180
-100
-1% -$8.91K 0.02% 359
2023
Q4
$797K Hold
7,280
0.03% 293
2023
Q3
$734K Hold
7,280
0.03% 289
2023
Q2
$989K Hold
7,280
0.04% 268
2023
Q1
$756K Buy
7,280
+400
+6% +$38.7K 0.03% 296
2022
Q4
$610K Buy
6,880
+180
+3% +$14.9K 0.03% 246
2022
Q3
$537K Hold
6,700
0.03% 293
2022
Q2
$642K Hold
6,700
0.03% 272
2022
Q1
$995K Buy
6,700
+100
+2% +$14K 0.05% 200
2021
Q4
$936K Buy
+6,600
New +$935K 0.05% 234

Other funds holding CNMD

NorthCrest Asset Manangement's CNMD Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its CONMED (CNMD) stake by 11% in Q2 2026, buying an estimated $23.4K and bringing the position to 6,660 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #797.

NorthCrest Asset Manangement first reported a position in CNMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $995K in Q1 2022. 56 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • NorthCrest Asset Manangement held 6,660 shares of CONMED worth $244K as of Q2 2026.
  • NorthCrest Asset Manangement bought 649 CONMED shares in Q2 2026, an estimated $23.4K.
  • CONMED made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #797 holding.
  • NorthCrest Asset Manangement first reported a position in CONMED in Q4 2021 and has held it in 19 quarters since.
  • NorthCrest Asset Manangement's CONMED position peaked at $995K in Q1 2022.
  • 56 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.